ASX - By Stock
|
NOX |
There is a lot going on
|
|
RBx
|
8 |
2.4K |
17 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
8
|
2.4K
|
17
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Veyonda To Be Tested In Combination With Opdivo In Trial
|
|
RBx
|
8 |
2.3K |
5 |
09/11/20 |
09/11/20 |
ASX - By Stock
|
8
|
2.3K
|
5
|
|
ASX - By Stock
|
NOX |
Join the dots
|
|
RBx
|
2 |
1.0K |
18 |
05/11/20 |
05/11/20 |
ASX - By Stock
|
2
|
1.0K
|
18
|
|
ASX - By Stock
|
NOX |
Trial update
|
|
RBx
|
6 |
4.0K |
13 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
6
|
4.0K
|
13
|
|
ASX - By Stock
|
NOX |
Re:
NOXCOVID-1 design
|
|
RBx
|
5 |
2.1K |
6 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
5
|
2.1K
|
6
|
|
ASX - By Stock
|
NOX |
NOXCOVID-1 design
|
|
RBx
|
5 |
2.1K |
9 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
5
|
2.1K
|
9
|
|
ASX - By Stock
|
NOX |
Re:
What do we know?
|
|
RBx
|
5 |
1.8K |
8 |
03/10/20 |
03/10/20 |
ASX - By Stock
|
5
|
1.8K
|
8
|
|
ASX - By Stock
|
NOX |
What do we know?
|
|
RBx
|
5 |
1.8K |
9 |
03/10/20 |
03/10/20 |
ASX - By Stock
|
5
|
1.8K
|
9
|
|
ASX - By Stock
|
NOX |
Protocol
|
|
RBx
|
3 |
2.1K |
10 |
19/09/20 |
19/09/20 |
ASX - By Stock
|
3
|
2.1K
|
10
|
|
ASX - By Stock
|
KZA |
Why has GBM AGILE added this drug?
|
|
RBx
|
7 |
1.3K |
3 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
7
|
1.3K
|
3
|
|
ASX - By Stock
|
NOX |
Immune video
|
|
RBx
|
0 |
283 |
2 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
0
|
283
|
2
|
|
ASX - By Stock
|
NOX |
Re:
NOXCOVID
|
|
RBx
|
8 |
2.6K |
4 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
8
|
2.6K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
NOXCOVID
|
|
RBx
|
8 |
2.6K |
3 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
8
|
2.6K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
NOXCOVID
|
|
RBx
|
8 |
2.6K |
4 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
8
|
2.6K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Global CRO To Execute DARRT-2 Prostate Cancer Study
|
|
RBx
|
1 |
726 |
6 |
08/09/20 |
08/09/20 |
ASX - By Stock
|
1
|
726
|
6
|
|
ASX - By Stock
|
NOX |
NOXCOVID
|
|
RBx
|
8 |
2.6K |
14 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
8
|
2.6K
|
14
|
|
ASX - By Stock
|
NOX |
Re:
Patent update
|
|
RBx
|
16 |
6.1K |
6 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
16
|
6.1K
|
6
|
|
ASX - By Stock
|
NOX |
Patent update
|
|
RBx
|
16 |
6.1K |
19 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
16
|
6.1K
|
19
|
|
ASX - By Stock
|
NOX |
EGM REVELATIONS
|
|
RBx
|
2 |
1.5K |
16 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
2
|
1.5K
|
16
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Discusses Converting Cold to Hot Cancer Tumours
|
|
RBx
|
3 |
1.6K |
9 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
3
|
1.6K
|
9
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Discusses Converting Cold to Hot Cancer Tumours
|
|
RBx
|
3 |
1.6K |
10 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
3
|
1.6K
|
10
|
|
ASX - By Stock
|
NOX |
Re:
Comments by Graham Kelly
|
|
RBx
|
14 |
5.3K |
5 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
14
|
5.3K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
Comments by Graham Kelly
|
|
RBx
|
14 |
5.3K |
0 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
14
|
5.3K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Comments by Graham Kelly
|
|
RBx
|
14 |
5.3K |
7 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
14
|
5.3K
|
7
|
|
ASX - By Stock
|
NOX |
Comments by Graham Kelly
|
|
RBx
|
14 |
5.3K |
21 |
27/06/20 |
27/06/20 |
ASX - By Stock
|
14
|
5.3K
|
21
|
|
ASX - By Stock
|
NOX |
Article in Herald Sun
|
|
RBx
|
0 |
289 |
8 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
0
|
289
|
8
|
|
ASX - By Stock
|
NOX |
Re:
Ann: COVID-19 Trial Program to Commence in Europe
|
|
RBx
|
6 |
2.7K |
4 |
26/06/20 |
26/06/20 |
ASX - By Stock
|
6
|
2.7K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Change in substantial holding
|
|
RBx
|
4 |
1.6K |
5 |
22/06/20 |
22/06/20 |
ASX - By Stock
|
4
|
1.6K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
Timing
|
|
RBx
|
23 |
7.1K |
8 |
20/06/20 |
20/06/20 |
ASX - By Stock
|
23
|
7.1K
|
8
|
|
ASX - By Stock
|
NOX |
Timing
|
|
RBx
|
23 |
7.1K |
7 |
19/06/20 |
19/06/20 |
ASX - By Stock
|
23
|
7.1K
|
7
|
|
ASX - By Stock
|
NOX |
Sign of confidence?
|
|
RBx
|
5 |
1.7K |
13 |
18/06/20 |
18/06/20 |
ASX - By Stock
|
5
|
1.7K
|
13
|
|
ASX - By Stock
|
NOX |
COVID news
|
|
RBx
|
1 |
658 |
8 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
1
|
658
|
8
|
|
ASX - By Stock
|
KZA |
TMZ data
|
|
RBx
|
3 |
1.0K |
1 |
09/06/20 |
09/06/20 |
ASX - By Stock
|
3
|
1.0K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
COVID IND
|
|
RBx
|
10 |
4.2K |
2 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
10
|
4.2K
|
2
|
|
ASX - By Stock
|
NOX |
COVID IND
|
|
RBx
|
10 |
4.2K |
10 |
26/05/20 |
26/05/20 |
ASX - By Stock
|
10
|
4.2K
|
10
|
|
ASX - By Stock
|
NOX |
Entitlement and Acceptance Form
|
|
RBx
|
0 |
399 |
2 |
23/05/20 |
23/05/20 |
ASX - By Stock
|
0
|
399
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Fascinating Interview
|
|
RBx
|
3 |
1.7K |
12 |
22/05/20 |
22/05/20 |
ASX - By Stock
|
3
|
1.7K
|
12
|
|
ASX - By Stock
|
NOX |
Fascinating Interview
|
|
RBx
|
3 |
1.7K |
15 |
22/05/20 |
22/05/20 |
ASX - By Stock
|
3
|
1.7K
|
15
|
|
ASX - By Stock
|
NOX |
Re:
Ann: FDA allows Veyonda Pre-IND Submission for COVID-19
|
|
RBx
|
16 |
7.1K |
16 |
19/05/20 |
19/05/20 |
ASX - By Stock
|
16
|
7.1K
|
16
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Veyonda Awarded First Allowed Patent Application
|
|
RBx
|
13 |
6.8K |
7 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
13
|
6.8K
|
7
|
|
ASX - By Stock
|
NOX |
Re:
Abscopal Blog
|
|
RBx
|
2 |
896 |
13 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
2
|
896
|
13
|
|
ASX - By Stock
|
NOX |
Abscopal Blog
|
|
RBx
|
2 |
896 |
8 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
2
|
896
|
8
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm March 2020 Quarterly Report & Appendix 4C
|
|
RBx
|
6 |
2.8K |
3 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
6
|
2.8K
|
3
|
|
ASX - By Stock
|
KZA |
In defence of James Garner
|
|
RBx
|
11 |
2.7K |
16 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
11
|
2.7K
|
16
|
|
ASX - By Stock
|
NOX |
Recent developments
|
|
RBx
|
1 |
622 |
9 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
1
|
622
|
9
|
|
ASX - By Stock
|
NOX |
Re:
FDA Emergency Use Authorization (EUA)
|
|
RBx
|
8 |
3.0K |
7 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
8
|
3.0K
|
7
|
|
ASX - By Stock
|
NYR |
Webinar
|
|
RBx
|
0 |
304 |
3 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
0
|
304
|
3
|
|
ASX - By Stock
|
NOX |
Re:
A potential blockbuster in Veyonda
|
|
RBx
|
4 |
2.3K |
6 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
4
|
2.3K
|
6
|
|
ASX - By Stock
|
NOX |
A potential blockbuster in Veyonda
|
|
RBx
|
4 |
2.3K |
9 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
4
|
2.3K
|
9
|
|
ASX - By Stock
|
NOX |
The Big Picture
|
|
RBx
|
2 |
1.1K |
10 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
2
|
1.1K
|
10
|
|